# Clinical Trial to Evaluate Pharmacokinetics, Pharmacodynamics and Safety of Leucostim® Compared to Neupogen®

> **NCT02762799** · PHASE1 · COMPLETED · sponsor: **Biocad** · enrollment: 60 (actual)

## Conditions studied

- Leucocytosis

## Interventions

- **BIOLOGICAL:** Leucostim®
- **BIOLOGICAL:** Neupogen®

## Key facts

- **NCT ID:** NCT02762799
- **Lead sponsor:** Biocad
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07-18
- **Primary completion:** 2016-11-11
- **Final completion:** 2016-11-11
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2018-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02762799

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02762799, "Clinical Trial to Evaluate Pharmacokinetics, Pharmacodynamics and Safety of Leucostim® Compared to Neupogen®". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT02762799. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*